Nadine Aldahhan, DO
Emergency Medicine · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 13 years
- University of North Texas Hsc, College of Osteopathic Med, 2013
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aldahhan’s office at (707) 521-4495 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$91,051
Medicare paid this office $91,051 for 391 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 245 | $38,036 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $16,600 | $147 |
| Long return visit (40+ min) | 65 | $10,814 | $166 |
| Short return visit (20+ min) | 145 | $8,657 | $56 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,569 | $275 |
See all 12 services
| Return visit (30+ min) | 245 | $38,036 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $16,600 | $147 |
| Long return visit (40+ min) | 65 | $10,814 | $166 |
| Short return visit (20+ min) | 145 | $8,657 | $56 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,569 | $275 |
| New patient visit (60+ min) | 16 | $3,051 | $191 |
| New patient visit (45+ min) | 11 | $1,463 | $133 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 59 | $1,054 | $15 |
| Influenza vaccine, inactivated | 11 | $900 | $82 |
| Administration of influenza virus vaccine | 16 | $658 | $39 |
| Administration of pneumococcal vaccine | 16 | $619 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $133 | $9 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 20 | 15 | 22 | 42 | 36 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
391 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 6% · Health risk score 0.92. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 54% · Cancer 19% · Chronic kidney disease 18% · Depression 18% · Coronary heart disease 17% · Atrial fibrillation 17% · Diabetes 12% · Heart failure 7% · COPD 7% · Stroke 6% · Dementia 5%.
The office billed $423,035, Medicare allowed $126,055 and paid $91,051; for 1,053 services of 43 kinds; $6,812 of it was for drugs given in the office and $84,239 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 391 | 1,053 | 76 | 0.92 | $423,035 | $91,051 |
| 2023 | 643 | 2,046 | 76 | 0.88 | $837,679 | $170,808 |
| 2022 | 767 | 2,074 | 76 | 0.88 | $848,559 | $184,201 |
| 2021 | 567 | 1,782 | 76 | 0.93 | $712,000 | $143,183 |
| 2020 | 563 | 2,092 | 75 | 0.95 | $607,357 | $100,839 |
| 2019 | 640 | 1,811 | 75 | 0.96 | $647,165 | $111,677 |
| 2018 | 427 | 1,421 | 75 | 0.88 | $182,764 | $68,336 |
| 2017 | 193 | 439 | 72 | 1.42 | $180,188 | $20,352 |
| 2016 | 74 | 126 | 72 | 1.60 | $42,877 | $8,320 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 369 | $64,177 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 297 | $43,547 | $147 |
| Short return visit (20+ min) | 260 | $22,010 | $71 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 43 | $11,497 | $267 |
| Influenza vaccine split virus, preservative free | 81 | $5,820 | $72 |
| Administration of influenza virus vaccine | 86 | $3,147 | $37 |
| Pneumococcal vaccine, 23-valent | 18 | $2,354 | $131 |
| Administration of pneumococcal vaccine | 61 | $2,232 | $37 |
| New patient visit (45+ min) | 13 | $1,938 | $149 |
| New patient visit (30+ min) | 17 | $1,415 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,408 | $67 |
| Removal of impacted ear wax | 35 | $1,066 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 67 | $840 | $12 |
| Injection of drug or substance under skin or into muscle | 22 | $583 | $12 |
| Urinalysis, manual test | 34 | $119 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 17 | $42 | None |
2022: 17 services
| Return visit (30+ min) | 400 | $72,800 | $113 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 351 | $51,203 | $146 |
| Short return visit (20+ min) | 282 | $26,806 | $82 |
| Pneumococcal vaccine, 23-valent | 42 | $5,551 | $132 |
| Influenza vaccine split virus, preservative free | 78 | $5,323 | $68 |
| New patient visit (45+ min) | 22 | $3,345 | $152 |
| Administration of influenza virus vaccine | 81 | $2,928 | $36 |
| New patient visit (30+ min) | 25 | $2,368 | $95 |
| Administration of pneumococcal vaccine | 45 | $1,640 | $36 |
| Removal of impacted ear wax | 39 | $1,313 | $31 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 20 | $1,014 | $51 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $953 | $60 |
| Injection of drug or substance under skin or into muscle | 19 | $813 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 56 | $609 | $10 |
| Urinalysis, manual test | 37 | $151 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 16 | $71 | None |
| Automated urinalysis test | 11 | $24 | $2 |
2021: 15 services
| Return visit (30+ min) | 270 | $41,508 | $105 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 247 | $37,108 | $150 |
| Short return visit (20+ min) | 322 | $36,698 | $68 |
| Pneumococcal vaccine, 23-valent | 57 | $7,129 | $125 |
| Influenza vaccine split virus, preservative free | 90 | $5,861 | $65 |
| New patient visit (45+ min) | 16 | $2,253 | $141 |
| Administration of influenza virus vaccine | 95 | $1,999 | $21 |
| New patient visit (30+ min) | 22 | $1,458 | $66 |
| Administration of pneumococcal vaccine | 58 | $1,219 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,189 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 89 | $1,088 | $11 |
| Short return visit | 13 | $797 | $57 |
| Removal of impacted ear wax | 21 | $648 | $29 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 11 | $616 | $51 |
| Urinalysis, manual test | 24 | $90 | $3 |
2020: 16 services
| Short return visit (20+ min) | 369 | $36,907 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 149 | $19,652 | $132 |
| Return visit (30+ min) | 153 | $17,790 | $91 |
| Pneumococcal vaccine, 23-valent | 47 | $5,418 | $115 |
| Influenza vaccine split virus, preservative free | 62 | $3,653 | $58 |
| New patient visit (30+ min) | 44 | $3,391 | $77 |
| New patient visit (45+ min) | 28 | $2,473 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,843 | $66 |
| Administration of influenza virus vaccine | 67 | $1,392 | $20 |
| Administration of pneumococcal vaccine | 52 | $1,045 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 64 | $946 | $14 |
| Injection of drug or substance under skin or into muscle | 18 | $560 | $12 |
| Removal of impacted ear wax | 14 | $514 | $34 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $159 | $9 |
| Urinalysis, manual test | 16 | $79 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 14 | $54 | None |
2019: 16 services
| Short return visit (20+ min) | 459 | $47,942 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 154 | $20,068 | $130 |
| Return visit (30+ min) | 117 | $12,691 | $91 |
| New patient visit (45+ min) | 70 | $9,344 | $133 |
| Influenza vaccine split virus, preservative free | 78 | $4,276 | $55 |
| New patient visit (30+ min) | 43 | $3,933 | $91 |
| Pneumococcal vaccine, 23-valent | 25 | $2,767 | $111 |
| Administration of influenza virus vaccine | 82 | $1,655 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 86 | $1,281 | $14 |
| Injection of drug or substance under skin or into muscle | 27 | $950 | $15 |
| Removal of impacted ear wax | 20 | $713 | $36 |
| Administration of pneumococcal vaccine | 32 | $646 | $20 |
| Inhalation treatment for airway obstruction or sputum production | 20 | $338 | $16 |
| Urinalysis, manual test | 34 | $130 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 24 | $73 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | $1 | None |
2018: 19 services
| Short return visit (20+ min) | 252 | $21,551 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 111 | $14,983 | $135 |
| Return visit (30+ min) | 116 | $12,193 | $90 |
| Influenza vaccine split virus, preservative free | 68 | $3,556 | $52 |
| Pneumococcal vaccine, 23-valent | 19 | $2,006 | $106 |
| Administration of influenza virus vaccine | 74 | $1,787 | $24 |
| Emergency department visit with moderate level of medical decision making | 14 | $1,246 | $83 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 32 | $916 | $29 |
| Annual alcohol misuse screening, 5 to 15 minutes | 32 | $698 | $22 |
| Annual depression screening, 5 to 15 minutes | 32 | $683 | $21 |
| Administration of pneumococcal vaccine | 25 | $602 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 38 | $584 | $15 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $550 | $42 |
| Emergency department visit with low level of medical decision making | 11 | $491 | $41 |
| Injection of drug or substance under skin or into muscle | 12 | $284 | $18 |
| Hemoglobin a1c level | 12 | $154 | $11 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $152 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $99 | $7 |
| Urinalysis, manual test | 17 | $61 | $3 |
2017: 8 services
| Emergency department visit with high level of medical decision making | 47 | $6,225 | $132 |
| Critical care, first 30-74 minutes | 17 | $3,831 | $167 |
| Short return visit (20+ min) | 67 | $3,328 | $46 |
| Return visit (30+ min) | 28 | $2,221 | $77 |
| Emergency department visit with moderate level of medical decision making | 14 | $846 | $56 |
| Injection of drug or substance under skin or into muscle | 18 | $453 | $20 |
| Inhalation treatment for airway obstruction or sputum production | 17 | $289 | $15 |
| Automated urinalysis test | 12 | $36 | $3 |
2016: 4 services
| Emergency department visit with high level of medical decision making | 17 | $2,265 | $126 |
| Emergency department visit with moderate level of medical decision making | 22 | $1,959 | $89 |
| Emergency department visit with low level of medical decision making | 15 | $657 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $193 | $6 |
Medicaid work
$73 in 2024
Medicaid paid $73 for 16 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 16 | $73 |
| 2024 | 16 | 1 | 16 | $73 |
| 2023 | 66 | 2 | 15 | $576 |
| 2022 | 68 | 2 | 19 | $896 |
| 2020 | 18 | 1 | 15 | $74 |
| 2018 | 167 | 1 | 36 | $795 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 37 | $554 |
| Return visit (30+ min) | 29 | $22 |
2022
| Short return visit (20+ min) | 36 | $546 |
| Return visit (30+ min) | 32 | $350 |
2020
| Short return visit (20+ min) | 18 | $74 |
2018
| Short return visit (20+ min) | 167 | $795 |
Drugs they prescribed that Part D paid
$166,922
Pharmacies billed $166,922 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (61 of 2,998) in 2024. At or below the middle of the specialty; the typical emergency medicine clinician is at 12%.
2,757 generic and fewer than 11 brand-name prescriptions · $166,922 in drug cost · 87 antibiotic prescriptions to 52 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 23 | $33,472 | $1,455 |
| Xarelto | 14 | $13,238 | $946 |
| Spiriva Handihaler | 14 | $7,504 | $536 |
| Qvar Redihaler | 14 | $4,162 | $297 |
| Rosuvastatin | 162 | $3,812 | $24 |
See all 57 drugs
| Eliquis | 23 | $33,472 | $1,455 |
| Xarelto | 14 | $13,238 | $946 |
| Spiriva Handihaler | 14 | $7,504 | $536 |
| Qvar Redihaler | 14 | $4,162 | $297 |
| Rosuvastatin | 162 | $3,812 | $24 |
| Atorvastatin | 269 | $3,351 | $12 |
| Ezetimibe | 33 | $2,257 | $68 |
| Levothyroxine | 181 | $2,209 | $12 |
| Lisinopril | 156 | $1,729 | $11 |
| Omeprazole | 96 | $1,626 | $17 |
| Gabapentin | 90 | $1,318 | $15 |
| Mirtazapine | 28 | $1,277 | $46 |
| Valacyclovir | 21 | $1,228 | $58 |
| Celecoxib | 19 | $1,226 | $65 |
| Amlodipine Besylate | 126 | $1,173 | $9 |
| Allopurinol | 80 | $1,150 | $14 |
| Tamsulosin | 58 | $1,129 | $19 |
| Escitalopram | 56 | $985 | $18 |
| Losartan | 95 | $980 | $10 |
| Hydrocodone-Acetaminophen | 49 | $952 | $19 |
| Famotidine | 17 | $945 | $56 |
| Bupropion Xl | 20 | $766 | $38 |
| Albuterol Sulfate Hfa | 29 | $749 | $26 |
| Trazodone | 72 | $696 | $10 |
| Metformin | 59 | $619 | $10 |
| Glipizide | 11 | $602 | $55 |
| Sertraline | 43 | $598 | $14 |
| Metoprolol | 33 | $589 | $18 |
| Estradiol | 16 | $563 | $35 |
| Doxycycline Hyclate | 18 | $528 | $29 |
| Acyclovir | 16 | $484 | $30 |
| Simvastatin | 45 | $463 | $10 |
| Lovastatin | 26 | $445 | $17 |
| Baclofen | 11 | $403 | $37 |
| Duloxetine | 13 | $378 | $29 |
| Pregabalin | 11 | $350 | $32 |
| Pantoprazole | 22 | $341 | $16 |
| Benazepril | 23 | $320 | $14 |
| Triamterene-Hydrochlorothiazid | 18 | $303 | $17 |
| Citalopram Hbr | 24 | $293 | $12 |
| Montelukast | 19 | $273 | $14 |
| Fluoxetine | 21 | $272 | $13 |
| Hydrochlorothiazide | 70 | $267 | $4 |
| Minocycline | 11 | $219 | $20 |
| Atenolol | 30 | $208 | $7 |
| Zolpidem | 29 | $207 | $7 |
| Amitriptyline | 13 | $191 | $15 |
| Lorazepam | 20 | $188 | $9 |
| Alendronate | 25 | $184 | $7 |
| Propranolol | 12 | $159 | $13 |
| Fluticasone Propionate | 21 | $152 | $7 |
| Furosemide | 20 | $152 | $8 |
| Metoprolol | 22 | $130 | $6 |
| Azithromycin | 26 | $101 | $4 |
| Triamcinolone Acetonide | 14 | $81 | $6 |
| Clopidogrel | 11 | $64 | $6 |
| Alprazolam | 16 | $57 | $4 |
Year by year
| 2024 | 2,998 | 492 | 2% (61) | None | $166,922 |
| 2023 | 4,976 | 724 | 2% (98) | 7% | $341,189 |
| 2022 | 5,172 | 805 | 2% (75) | 9% | $364,323 |
| 2021 | 4,717 | 663 | 3% (126) | None | $266,976 |
| 2020 | 4,461 | 678 | 3% (120) | None | $250,386 |
| 2019 | 3,319 | 558 | 2% (68) | None | $221,806 |
| 2018 | 1,303 | 401 | 3% (35) | None | $59,346 |
| 2017 | 380 | 141 | 3% (12) | None | $19,074 |
| 2016 | 514 | 80 | None | None | $28,779 |
| 2015 | 361 | 56 | None | 11% | $15,998 |
| 2014 | 64 | 15 | 0% (0) | None | $1,418 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 81 drugs
| Eliquis | 45 | $72,511 | $1,611 |
| Ozempic | 16 | $17,282 | $1,080 |
| Xarelto | 14 | $15,407 | $1,101 |
| Rosuvastatin | 170 | $7,478 | $44 |
| Qvar Redihaler | 18 | $6,088 | $338 |
| Famotidine | 34 | $6,074 | $179 |
| Levothyroxine | 323 | $5,825 | $18 |
| Atorvastatin | 405 | $5,505 | $14 |
| Ezetimibe | 51 | $4,656 | $91 |
| Aripiprazole | 13 | $4,074 | $313 |
| Gabapentin | 154 | $3,588 | $23 |
| Testosterone | 16 | $3,234 | $202 |
| Bupropion Xl | 36 | $3,231 | $90 |
| Flovent Hfa | 11 | $3,042 | $277 |
| Lisinopril | 307 | $3,003 | $10 |
| Escitalopram | 115 | $2,773 | $24 |
| Valacyclovir | 38 | $2,667 | $70 |
| Omeprazole | 134 | $2,624 | $20 |
| Amlodipine Besylate | 200 | $2,086 | $10 |
| Tamsulosin | 81 | $1,924 | $24 |
| Celecoxib | 42 | $1,918 | $46 |
| Losartan | 110 | $1,744 | $16 |
| Allopurinol | 83 | $1,693 | $20 |
| Albuterol Sulfate Hfa | 60 | $1,671 | $28 |
| Hydrocodone-Acetaminophen | 69 | $1,669 | $24 |
| Estradiol | 35 | $1,639 | $47 |
| Oxycodone | 22 | $1,639 | $75 |
| Metoprolol | 74 | $1,418 | $19 |
| Simvastatin | 98 | $1,379 | $14 |
| Pantoprazole | 47 | $1,352 | $29 |
| Bupropion Hcl Sr | 28 | $1,330 | $48 |
| Doxycycline Hyclate | 32 | $1,270 | $40 |
| Trazodone | 95 | $1,238 | $13 |
| Synthroid | 12 | $1,222 | $102 |
| Mirtazapine | 39 | $1,130 | $29 |
| Sertraline | 78 | $1,104 | $14 |
| Alendronate | 59 | $991 | $17 |
| Duloxetine | 28 | $908 | $32 |
| Metformin | 86 | $896 | $10 |
| Baclofen | 22 | $785 | $36 |
| Colchicine | 12 | $752 | $63 |
| Montelukast | 29 | $741 | $26 |
| Hydrochlorothiazide | 100 | $702 | $7 |
| Citalopram Hbr | 43 | $695 | $16 |
| Acyclovir | 28 | $651 | $23 |
| Benazepril | 32 | $605 | $19 |
| Propranolol | 19 | $597 | $31 |
| Zolpidem | 68 | $594 | $9 |
| Levetiracetam | 13 | $555 | $43 |
| Fluticasone Propionate | 35 | $540 | $15 |
| Potassium Chloride | 17 | $538 | $32 |
| Lovastatin | 38 | $512 | $13 |
| Finasteride | 23 | $474 | $21 |
| Quetiapine | 18 | $471 | $26 |
| Cephalexin | 44 | $421 | $10 |
| Fluoxetine | 23 | $387 | $17 |
| Nitrofurantoin Mono-Macro | 26 | $377 | $14 |
| Oxybutynin Chloride Er | 13 | $370 | $28 |
| Paxlovid (Eua) | 37 | $369 | $10 |
| Lorazepam | 53 | $341 | $6 |
| Triamterene-Hydrochlorothiazid | 18 | $316 | $18 |
| Glipizide | 23 | $310 | $13 |
| Atenolol | 36 | $309 | $9 |
| Carvedilol | 13 | $244 | $19 |
| Amoxicillin-Clavulanate Potass | 19 | $243 | $13 |
| Furosemide | 30 | $240 | $8 |
| Azithromycin | 42 | $222 | $5 |
| Triamcinolone Acetonide | 28 | $216 | $8 |
| Sumatriptan | 19 | $210 | $11 |
| Clopidogrel | 14 | $190 | $14 |
| Metoprolol | 27 | $174 | $6 |
| Losartan-Hydrochlorothiazide | 12 | $157 | $13 |
| Pravastatin | 16 | $135 | $8 |
| Methylphenidate | 11 | $130 | $12 |
| Cyclobenzaprine | 15 | $123 | $8 |
| Mupirocin | 12 | $121 | $10 |
| Temazepam | 13 | $75 | $6 |
| Meloxicam | 13 | $69 | $5 |
| Alprazolam | 18 | $63 | $4 |
| Diazepam | 13 | $47 | $4 |
| Amoxicillin | 12 | $35 | $3 |
2022: 83 drugs
| Eliquis | 63 | $82,484 | $1,309 |
| Xarelto | 17 | $24,807 | $1,459 |
| Levothyroxine | 394 | $7,776 | $20 |
| Flovent Hfa | 15 | $7,182 | $479 |
| Atorvastatin | 439 | $6,178 | $14 |
| Rosuvastatin | 134 | $6,142 | $46 |
| Lantus Solostar | 14 | $5,997 | $428 |
| Famotidine | 38 | $5,926 | $156 |
| Gabapentin | 159 | $5,286 | $33 |
| Ezetimibe | 40 | $5,116 | $128 |
| Aripiprazole | 15 | $3,935 | $262 |
| Escitalopram | 158 | $3,268 | $21 |
| Omeprazole | 134 | $2,857 | $21 |
| Valacyclovir | 43 | $2,855 | $66 |
| Testosterone | 12 | $2,733 | $228 |
| Tamsulosin | 100 | $2,478 | $25 |
| Duloxetine | 46 | $2,320 | $50 |
| Bupropion Xl | 38 | $2,211 | $58 |
| Lisinopril | 285 | $2,197 | $8 |
| Allopurinol | 102 | $2,164 | $21 |
| Doxycycline Hyclate | 32 | $1,951 | $61 |
| Estradiol | 30 | $1,906 | $64 |
| Amlodipine Besylate | 191 | $1,785 | $9 |
| Albuterol Sulfate Hfa | 39 | $1,695 | $43 |
| Synthroid | 19 | $1,545 | $81 |
| Mirtazapine | 30 | $1,421 | $47 |
| Metoprolol | 81 | $1,368 | $17 |
| Losartan | 101 | $1,337 | $13 |
| Pantoprazole | 37 | $1,334 | $36 |
| Hydrocodone-Acetaminophen | 50 | $1,272 | $25 |
| Trazodone | 98 | $1,190 | $12 |
| Sertraline | 74 | $1,178 | $16 |
| Potassium Chloride | 35 | $1,105 | $32 |
| Simvastatin | 102 | $1,066 | $10 |
| Celecoxib | 25 | $975 | $39 |
| Metformin | 93 | $917 | $10 |
| Quetiapine | 26 | $876 | $34 |
| Fluticasone Propionate | 36 | $843 | $23 |
| Losartan-Hydrochlorothiazide | 17 | $835 | $49 |
| Citalopram Hbr | 47 | $770 | $16 |
| Bupropion Hcl Sr | 19 | $758 | $40 |
| Alendronate | 59 | $725 | $12 |
| Oxycodone | 11 | $701 | $64 |
| Acyclovir | 49 | $686 | $14 |
| Hydrochlorothiazide | 104 | $681 | $7 |
| Fluoxetine | 44 | $679 | $15 |
| Finasteride | 33 | $653 | $20 |
| Lovastatin | 38 | $645 | $17 |
| Olmesartan Medoxomil | 17 | $609 | $36 |
| Oxybutynin Chloride Er | 12 | $570 | $47 |
| Nitrofurantoin Mono-Macro | 32 | $532 | $17 |
| Furosemide | 59 | $531 | $9 |
| Montelukast | 19 | $495 | $26 |
| Propranolol | 19 | $494 | $26 |
| Rizatriptan | 16 | $489 | $31 |
| Lorazepam | 73 | $459 | $6 |
| Donepezil | 22 | $443 | $20 |
| Benazepril | 21 | $436 | $21 |
| Zolpidem | 70 | $436 | $6 |
| Venlafaxine Hcl Er | 11 | $394 | $36 |
| Valsartan | 11 | $386 | $35 |
| Levetiracetam | 12 | $362 | $30 |
| Atenolol | 30 | $323 | $11 |
| Cephalexin | 24 | $279 | $12 |
| Spironolactone | 14 | $262 | $19 |
| Carvedilol | 19 | $261 | $14 |
| Triamterene-Hydrochlorothiazid | 23 | $245 | $11 |
| Pravastatin | 15 | $212 | $14 |
| Triamcinolone Acetonide | 26 | $198 | $8 |
| Clopidogrel | 19 | $183 | $10 |
| Lisinopril-Hydrochlorothiazide | 12 | $154 | $13 |
| Glipizide | 17 | $152 | $9 |
| Azithromycin | 24 | $151 | $6 |
| Metoprolol | 23 | $145 | $6 |
| Cyclobenzaprine | 14 | $143 | $10 |
| Sumatriptan | 14 | $141 | $10 |
| Paxlovid (Eua) | 13 | $123 | $9 |
| Zaleplon | 12 | $119 | $10 |
| Baclofen | 14 | $108 | $8 |
| Temazepam | 13 | $89 | $7 |
| Diazepam | 21 | $78 | $4 |
| Meloxicam | 13 | $72 | $6 |
| Alprazolam | 19 | $43 | $2 |
2021: 77 drugs
| Eliquis | 50 | $59,902 | $1,198 |
| Levothyroxine | 372 | $8,191 | $22 |
| Advair Diskus | 16 | $7,265 | $454 |
| Famotidine | 35 | $7,058 | $202 |
| Symbicort | 17 | $6,957 | $409 |
| Atorvastatin | 397 | $5,801 | $15 |
| Rosuvastatin | 99 | $4,682 | $47 |
| Flovent Hfa | 13 | $4,413 | $339 |
| Ezetimibe | 32 | $3,099 | $97 |
| Gabapentin | 127 | $3,042 | $24 |
| Valacyclovir | 38 | $2,764 | $73 |
| Albuterol Sulfate Hfa | 57 | $2,573 | $45 |
| Tamsulosin | 118 | $2,372 | $20 |
| Escitalopram | 129 | $2,311 | $18 |
| Allopurinol | 89 | $2,119 | $24 |
| Omeprazole | 112 | $2,111 | $19 |
| Duloxetine | 31 | $2,037 | $66 |
| Hydrocodone-Acetaminophen | 77 | $1,961 | $25 |
| Lisinopril | 272 | $1,868 | $7 |
| Synthroid | 21 | $1,724 | $82 |
| Doxycycline Hyclate | 27 | $1,711 | $63 |
| Bupropion Xl | 22 | $1,676 | $76 |
| Amlodipine Besylate | 159 | $1,390 | $9 |
| Losartan | 86 | $1,311 | $15 |
| Metoprolol | 70 | $1,246 | $18 |
| Sertraline | 67 | $1,242 | $19 |
| Bupropion Hcl Sr | 14 | $1,081 | $77 |
| Pantoprazole | 32 | $1,068 | $33 |
| Simvastatin | 106 | $1,061 | $10 |
| Mirtazapine | 19 | $1,047 | $55 |
| Potassium Chloride | 31 | $1,013 | $33 |
| Trazodone | 75 | $998 | $13 |
| Fluoxetine | 50 | $964 | $19 |
| Celecoxib | 17 | $928 | $55 |
| Valsartan | 12 | $921 | $77 |
| Finasteride | 32 | $891 | $28 |
| Estradiol | 17 | $870 | $51 |
| Olmesartan Medoxomil | 17 | $807 | $47 |
| Spironolactone | 31 | $766 | $25 |
| Oxycodone-Acetaminophen | 21 | $726 | $35 |
| Metformin | 77 | $720 | $9 |
| Fluticasone Propionate | 29 | $718 | $25 |
| Levetiracetam | 17 | $704 | $41 |
| Alendronate | 55 | $701 | $13 |
| Hydrochlorothiazide | 101 | $689 | $7 |
| Acyclovir | 46 | $677 | $15 |
| Propranolol | 31 | $675 | $22 |
| Lovastatin | 37 | $654 | $18 |
| Nitrofurantoin Mono-Macro | 31 | $531 | $17 |
| Lorazepam | 72 | $524 | $7 |
| Citalopram Hbr | 38 | $503 | $13 |
| Felodipine Er | 11 | $498 | $45 |
| Pravastatin | 25 | $496 | $20 |
| Zolpidem | 78 | $378 | $5 |
| Montelukast | 19 | $310 | $16 |
| Atenolol | 32 | $308 | $10 |
| Oxycodone | 11 | $299 | $27 |
| Furosemide | 37 | $256 | $7 |
| Metoprolol | 27 | $230 | $9 |
| Triamterene-Hydrochlorothiazid | 17 | $229 | $13 |
| Triamcinolone Acetonide | 25 | $209 | $8 |
| Donepezil | 15 | $203 | $14 |
| Lisinopril-Hydrochlorothiazide | 19 | $203 | $11 |
| Zaleplon | 15 | $190 | $13 |
| Cephalexin | 13 | $160 | $12 |
| Baclofen | 14 | $148 | $11 |
| Mupirocin | 13 | $138 | $11 |
| Quetiapine | 14 | $126 | $9 |
| Clopidogrel | 11 | $123 | $11 |
| Cyclobenzaprine | 18 | $120 | $7 |
| Glipizide | 15 | $115 | $8 |
| Tramadol | 13 | $109 | $8 |
| Alprazolam | 23 | $91 | $4 |
| Temazepam | 14 | $77 | $6 |
| Diazepam | 21 | $68 | $3 |
| Clonazepam | 12 | $57 | $5 |
| Ciprofloxacin | 14 | $38 | $3 |
2020: 81 drugs
| Eliquis | 39 | $34,548 | $886 |
| Januvia | 12 | $9,503 | $792 |
| Levothyroxine | 357 | $8,144 | $23 |
| Atorvastatin | 346 | $5,811 | $17 |
| Testosterone | 16 | $5,301 | $331 |
| Aripiprazole | 14 | $4,810 | $344 |
| Premarin | 11 | $4,484 | $408 |
| Rosuvastatin | 50 | $3,765 | $75 |
| Colchicine | 16 | $3,636 | $227 |
| Valacyclovir | 53 | $3,251 | $61 |
| Lisinopril | 291 | $2,245 | $8 |
| Tamsulosin | 116 | $2,186 | $19 |
| Ezetimibe | 19 | $2,139 | $113 |
| Wixela Inhub | 11 | $2,018 | $183 |
| Albuterol Sulfate Hfa | 45 | $2,003 | $45 |
| Gabapentin | 91 | $1,937 | $21 |
| Proair Hfa | 24 | $1,937 | $81 |
| Omeprazole | 115 | $1,935 | $17 |
| Metoprolol | 68 | $1,864 | $27 |
| Duloxetine | 36 | $1,863 | $52 |
| Allopurinol | 85 | $1,803 | $21 |
| Doxycycline Hyclate | 39 | $1,785 | $46 |
| Celecoxib | 19 | $1,730 | $91 |
| Fluoxetine | 43 | $1,522 | $35 |
| Hydrocodone-Acetaminophen | 78 | $1,503 | $19 |
| Escitalopram | 86 | $1,445 | $17 |
| Synthroid | 16 | $1,395 | $87 |
| Amlodipine Besylate | 145 | $1,287 | $9 |
| Simvastatin | 104 | $1,260 | $12 |
| Trazodone | 85 | $1,177 | $14 |
| Famotidine | 31 | $1,161 | $37 |
| Losartan | 57 | $1,094 | $19 |
| Bupropion Xl | 13 | $1,073 | $83 |
| Potassium Chloride | 29 | $989 | $34 |
| Sertraline | 80 | $900 | $11 |
| Propranolol | 34 | $873 | $26 |
| Mirtazapine | 16 | $867 | $54 |
| Ventolin Hfa | 13 | $858 | $66 |
| Alendronate | 60 | $828 | $14 |
| Pantoprazole | 32 | $776 | $24 |
| Lovastatin | 35 | $771 | $22 |
| Hydrochlorothiazide | 98 | $688 | $7 |
| Finasteride | 23 | $683 | $30 |
| Oxycodone-Acetaminophen | 14 | $619 | $44 |
| Acyclovir | 45 | $566 | $13 |
| Pravastatin | 23 | $557 | $24 |
| Spironolactone | 20 | $554 | $28 |
| Metformin | 49 | $545 | $11 |
| Irbesartan | 13 | $541 | $42 |
| Zolpidem | 79 | $514 | $7 |
| Nitrofurantoin Mono-Macro | 29 | $508 | $18 |
| Citalopram Hbr | 27 | $492 | $18 |
| Triamterene-Hydrochlorothiazid | 28 | $480 | $17 |
| Fluticasone Propionate | 19 | $477 | $25 |
| Lorazepam | 67 | $448 | $7 |
| Benazepril | 17 | $400 | $24 |
| Glipizide Er | 18 | $387 | $21 |
| Atenolol | 33 | $373 | $11 |
| Olmesartan Medoxomil | 12 | $366 | $31 |
| Triamcinolone Acetonide | 33 | $351 | $11 |
| Ropinirole | 12 | $331 | $28 |
| Furosemide | 36 | $320 | $9 |
| Montelukast | 18 | $269 | $15 |
| Ketoconazole | 16 | $249 | $16 |
| Estradiol | 12 | $243 | $20 |
| Risperidone | 12 | $206 | $17 |
| Hydralazine | 12 | $204 | $17 |
| Mupirocin | 22 | $201 | $9 |
| Prednisone | 14 | $182 | $13 |
| Azithromycin | 25 | $179 | $7 |
| Metoprolol | 15 | $170 | $11 |
| Glipizide | 12 | $167 | $14 |
| Zaleplon | 15 | $162 | $11 |
| Cephalexin | 18 | $137 | $8 |
| Lisinopril-Hydrochlorothiazide | 13 | $128 | $10 |
| Tramadol | 16 | $121 | $8 |
| Cyclobenzaprine | 20 | $119 | $6 |
| Meloxicam | 11 | $95 | $9 |
| Carvedilol | 13 | $95 | $7 |
| Alprazolam | 24 | $54 | $2 |
| Diazepam | 18 | $50 | $3 |
2019: 74 drugs
| Eliquis | 23 | $20,416 | $888 |
| Symbicort | 17 | $5,823 | $343 |
| Spiriva Respimat | 13 | $5,814 | $447 |
| Levothyroxine | 218 | $5,218 | $24 |
| Atorvastatin | 237 | $5,007 | $21 |
| Aripiprazole | 13 | $4,353 | $335 |
| Potassium Chloride | 30 | $3,256 | $109 |
| Valacyclovir | 42 | $3,085 | $73 |
| Asmanex | 11 | $3,074 | $279 |
| Flovent Hfa | 12 | $2,754 | $229 |
| Bupropion Xl | 18 | $2,092 | $116 |
| Lisinopril | 181 | $1,907 | $11 |
| Allopurinol | 85 | $1,832 | $22 |
| Duloxetine | 28 | $1,757 | $63 |
| Gabapentin | 51 | $1,531 | $30 |
| Rosuvastatin | 14 | $1,494 | $107 |
| Omeprazole | 76 | $1,481 | $19 |
| Celecoxib | 18 | $1,422 | $79 |
| Simvastatin | 120 | $1,393 | $12 |
| Ventolin Hfa | 23 | $1,352 | $59 |
| Metoprolol | 65 | $1,351 | $21 |
| Proair Hfa | 19 | $1,314 | $69 |
| Famotidine | 22 | $1,272 | $58 |
| Hydrocodone-Acetaminophen | 47 | $1,173 | $25 |
| Escitalopram | 47 | $1,133 | $24 |
| Metronidazole | 12 | $971 | $81 |
| Tamsulosin | 50 | $957 | $19 |
| Amlodipine Besylate | 111 | $814 | $7 |
| Alendronate | 52 | $764 | $15 |
| Nitrofurantoin Mono-Macro | 36 | $743 | $21 |
| Losartan | 51 | $742 | $15 |
| Lovastatin | 40 | $647 | $16 |
| Sertraline | 42 | $644 | $15 |
| Bupropion Hcl Sr | 14 | $635 | $45 |
| Doxycycline Hyclate | 19 | $616 | $32 |
| Trazodone | 56 | $612 | $11 |
| Estradiol | 13 | $552 | $42 |
| Finasteride | 12 | $546 | $46 |
| Fluoxetine | 32 | $536 | $17 |
| Pantoprazole | 23 | $534 | $23 |
| Atenolol | 30 | $458 | $15 |
| Zolpidem | 53 | $449 | $8 |
| Glipizide Er | 23 | $445 | $19 |
| Azithromycin | 51 | $432 | $8 |
| Hydrochlorothiazide | 82 | $427 | $5 |
| Pravastatin | 11 | $420 | $38 |
| Sumatriptan | 14 | $391 | $28 |
| Propranolol | 12 | $380 | $32 |
| Fluticasone Propionate | 22 | $353 | $16 |
| Levetiracetam | 12 | $346 | $29 |
| Donepezil | 13 | $337 | $26 |
| Spironolactone | 11 | $332 | $30 |
| Citalopram Hbr | 17 | $316 | $19 |
| Enalapril Maleate | 13 | $307 | $24 |
| Benazepril | 20 | $300 | $15 |
| Furosemide | 30 | $300 | $10 |
| Metformin | 25 | $288 | $12 |
| Lorazepam | 35 | $274 | $8 |
| Amoxicillin-Clavulanate Potass | 19 | $260 | $14 |
| Clopidogrel | 14 | $240 | $17 |
| Montelukast | 13 | $227 | $17 |
| Ketoconazole | 12 | $221 | $18 |
| Triamcinolone Acetonide | 30 | $207 | $7 |
| Metformin Hcl Er | 17 | $205 | $12 |
| Olmesartan Medoxomil | 12 | $181 | $15 |
| Acyclovir | 18 | $171 | $10 |
| Mupirocin | 14 | $165 | $12 |
| Metoprolol | 11 | $122 | $11 |
| Lisinopril-Hydrochlorothiazide | 14 | $112 | $8 |
| Tramadol | 11 | $92 | $8 |
| Prednisone | 21 | $73 | $3 |
| Alprazolam | 14 | $53 | $4 |
| Amoxicillin | 11 | $45 | $4 |
| Clonazepam | 14 | $30 | $2 |
2018: 32 drugs
| Levothyroxine | 90 | $1,847 | $21 |
| Atorvastatin | 61 | $1,463 | $24 |
| Ventolin Hfa | 22 | $1,462 | $66 |
| Potassium Chloride | 14 | $1,115 | $80 |
| Metoprolol | 34 | $1,039 | $31 |
| Valacyclovir | 14 | $705 | $50 |
| Nitrofurantoin Mono-Macro | 27 | $646 | $24 |
| Hydrocodone-Acetaminophen | 23 | $560 | $24 |
| Escitalopram | 23 | $556 | $24 |
| Gabapentin | 19 | $458 | $24 |
| Losartan | 32 | $376 | $12 |
| Allopurinol | 18 | $366 | $20 |
| Amlodipine Besylate | 51 | $306 | $6 |
| Tamsulosin | 16 | $304 | $19 |
| Lisinopril | 44 | $292 | $7 |
| Simvastatin | 39 | $290 | $7 |
| Lovastatin | 18 | $286 | $16 |
| Omeprazole | 19 | $285 | $15 |
| Nitrofurantoin | 13 | $282 | $22 |
| Zolpidem | 25 | $210 | $8 |
| Warfarin | 11 | $206 | $19 |
| Azithromycin | 24 | $197 | $8 |
| Metformin | 23 | $191 | $8 |
| Clopidogrel | 13 | $184 | $14 |
| Hydrochlorothiazide | 26 | $177 | $7 |
| Alendronate | 12 | $162 | $13 |
| Losartan-Hydrochlorothiazide | 13 | $146 | $11 |
| Lorazepam | 18 | $142 | $8 |
| Trazodone | 23 | $130 | $6 |
| Metoprolol | 15 | $71 | $5 |
| Amoxicillin | 12 | $53 | $4 |
| Prednisone | 11 | $35 | $3 |
2017: 6 drugs
| Atorvastatin | 17 | $264 | $16 |
| Lisinopril | 27 | $170 | $6 |
| Azithromycin | 17 | $114 | $7 |
| Amlodipine Besylate | 16 | $80 | $5 |
| Metoprolol | 18 | $61 | $3 |
| Simvastatin | 11 | $27 | $2 |
2016: 11 drugs
| Crestor | 15 | $3,743 | $250 |
| Levothyroxine | 25 | $423 | $17 |
| Gabapentin | 20 | $249 | $12 |
| Clopidogrel | 23 | $211 | $9 |
| Metformin | 34 | $186 | $5 |
| Atorvastatin | 18 | $183 | $10 |
| Lisinopril | 40 | $160 | $4 |
| Simvastatin | 31 | $160 | $5 |
| Metoprolol | 25 | $112 | $4 |
| Lisinopril-Hydrochlorothiazide | 21 | $108 | $5 |
| Hydrochlorothiazide | 12 | $25 | $2 |
2015: 10 drugs
| Levothyroxine | 20 | $518 | $26 |
| Tizanidine | 11 | $391 | $36 |
| Cyclobenzaprine | 20 | $224 | $11 |
| Pravastatin | 11 | $175 | $16 |
| Metformin | 20 | $120 | $6 |
| Ibuprofen | 17 | $117 | $7 |
| Simvastatin | 18 | $96 | $5 |
| Lisinopril-Hydrochlorothiazide | 18 | $92 | $5 |
| Metoprolol | 24 | $88 | $4 |
| Lisinopril | 15 | $48 | $3 |
Money from drug and device companies
$128 in 2019
A payment is not proof that care is biased.
| Amgen | None | $110 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent | $18 | 1 payment
|
See all 2 published payments
| Sanofi Pasteur | Meals · 2019-10-21 | Fluzone Quadrivalent | $18 |
| Amgen | Meals · 2019-02-26 | None | $110 |
Professional record
- NPI
- 1609202308
- Licence
- CA 20A14150
- Trained
- University of North Texas Hsc, College of Osteopathic Med, 2013 · 13 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 207PE0004X (207PE0004X)
- Mailing address
- 3 Harbor Dr Ste 111, Sausalito, CA, 94965
- NPI first listed
- 2013-09-25
- NPI last updated
- 2019-01-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3883 Airway Dr Ste 120, Santa Rosa, CA, 95403